Clinical Trials Sponsored by Ajinomoto Co., Inc.

Total 841 results

Eisai Co., Ltd.

Completed

Safety and Pharmacokinetics Study of E2007 to Treat Partial and Generalised Seizures in People With Epilepsy

Epilepsy

Germany
Eisai Co., Ltd.

Completed

E7777 for the Treatment of Patients With Peripheral T-Cell Lymphoma

Peripheral T-Cell Lymphoma

Japan
Eisai Co., Ltd.

Completed

Post-Marketing Surveillance of Long-Term Observation of Gliadel Wafer-Investigation of Vital Prognosis in Patients With High Grade Glioma

Malignant Glioma

Japan
Eisai Co., Ltd.

Completed

Investigation of the Safety and Efficacy of Eszopiclone in Insomnia Patients

Insomnia

Japan
Eisai Co., Ltd.

Completed

Post-marketing Surveillance of Donepezil Hydrochloride - Investigation of Long Term Safety and Efficacy of Aricept as Well as Its Proper Use Information in Patients With Dementia With Lewy Bodies (DLB).

Dementia With Lewy Body Disease

Japan
Eisai Co., Ltd.

Completed

An Open-label Extension Study to Evaluate the Safety and Tolerability of Perampanel (E2007) Administered as an Adjunctive Therapy in Epilepsy Subjects

Epilepsy

Japan
Eisai Co., Ltd.

Completed

A Study of E7050 Administered Orally to Patients With Advanced Solid Tumors

Solid Tumors

Japan
Eisai Co., Ltd.

Completed

Study to Evaluate the Safety and Tolerability of a Once Daily Dose of 50 mg E2609 in Healthy Japanese Subjects

Healthy Participants

Japan
Eisai Co., Ltd.

Completed

Study to Evaluate the Effect of Diltiazem Extended Release on the Pharmacokinetics of E2027 in Healthy Subjects

Healthy Subjects

United States
Eisai Co., Ltd.

Completed

An Open-label, Multicenter, Phase 2 Study to Evaluate the Efficacy and Safety of Eribulin Mesylate in Previously Treated Subjects With Advanced or Metastatic Soft Tissue Sarcoma (Study E7389-J081-217)

Soft Tissue Sarcoma

Japan
Eisai Co., Ltd.

Completed

Long-term Prevention of Recurrent Gastric or Duodenal Ulcers Caused by Low-dose Aspirin With Rabeprazole (E3810) Treatment (Planetarium Study)

Gastric Ulcers Duodenal Ulcers Caused by Low-dose Aspirin

Japan
Eisai Co., Ltd.

Completed

A Clinical Study in Healthy Male Volunteers to Compare the Bioequivalence of Fixed Dose Combination of Eperisone Hydrochloride 50mg Plus Diclofenac Sodium 50mg as Capsule With Eperisone Hydrochloride 50mg and Diclofenac Sodium 50mg Tablets Under Fasting Conditions (Study 013-10)

Healthy Volunteers

India
Eisai Co., Ltd.

Completed

A Randomized, Double-blind, Placebo-controlled Study to Assess Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Pharmacodynamic Response of Repeated Intravenous Infusions of BAN2401 in Subjects With Mild Cognitive Impairment Due to Alzheimer's Disease and Mild Alzheimer's Disease

Alzheimer's Disease

Japan
Eisai Co., Ltd.

Completed

A Study of E2022 Tape Formulation (Overlay-integrated E2022 18 mg Tape Formulation) for Different Application Sites and Intervals in Japanese Healthy Elderly Males

Healthy Subjects

Japan
Eisai Co., Ltd.

Completed

A Multiple Dose Pharmacokinetic Study of Perampanel in Korean Healthy Subjects

Healthy

Korea, Republic of
Eisai Co., Ltd.

Completed

A Phase 1 Study of Single-dose Subcutaneous E6011 in Japanese Healthy Adult Male Subjects

Healthy

Japan
Eisai Co., Ltd.

Completed

A Phase I Study of E7050 in Subjects With Solid Tumors

Gastric Cancer | Solid Tumor

Japan
Eisai Co., Ltd.

Completed

A Phase 1 Single Dose Study of E6011 in Japanese Healthy Adult Male Subjects (Study E6011-J081-001)

Healthy Male Volunteers

Japan
Eisai Co., Ltd.

Completed

A Single-dose Study in Healthy Japanese Male Adults to Evaluate Pharmacokinetics and Pharmacodynamics of E5501 5 mg Tablet (Study E5501-J081-015)

Healthy

Japan
Eisai Co., Ltd.

Terminated

A Study of E7070 in Patients With Gastric Cancer

Gastric Cancer

Japan
Eisai Co., Ltd.

Completed

Study of E7389 for Advanced or Metastatic Breast Cancer

Breast Cancer

Japan
Eisai Inc.
Eisai Co., Ltd.

Completed

Effects of Combination Therapy With Alpha-1 Blocker (Bunazosin or Doxazosin) in the Treatment of Patients With Mild to Moderate Essential Hypertension

High Blood Pressure

Taiwan
Eisai Co., Ltd.

Completed

An Study of Efficacy and Safety of Clevudine

Chronic Hepatitis B

China
Eisai Co., Ltd.

Completed

E2022 Patch Formulation Single Dose Phase I Study

Japanese Healthy Male Adult Volunteers

Japan
Eisai Co., Ltd.

Completed

Pharmacokinetics Study of Donepezil HCl in Subjects Receiving Haemodialysis.

End-Stage Renal Disease

Japan
Eisai Co., Ltd.

Completed

A Double-Blind Study of E5555 in Japanese Patients With Acute Coronary Syndrome

Acute Coronary Syndrome

Japan
Eisai Co., Ltd.

Completed

Study of E3810 for Healthy Japanese Male (Under Fasting Condition)

Healthy
Eisai Co., Ltd.

Completed

A Bioequivalence and Food Effect Study of SEP-190 in Japanese Healthy Subjects (Study SEP 190-102)

Insomnia

Japan
Eisai Co., Ltd.

Completed

An add-on Study of E2007 in Patients With Refractory Partial Seizures Uncontrolled With Other Anti-epileptic Drugs (AEDs)

Refractory Partial Seizures

Japan
Eisai Co., Ltd.

Completed

A Clinical Trial to Study the Effects of a Fixed Dose Combination of Diclofenac and Eperisone Hydrochloride With Plain Eperisone Hydrochloride in Patients With Low Back Pain

Acute Musculoskeletal Spasm Due to Low Back Pain

India
Eisai Co., Ltd.

Completed

A Clinical Pharmacological Study of Rabeprazole Sodium in Japanese Healthy Adult Male Volunteers (Study E3810)

Healthy

Japan
Eisai Co., Ltd.

Recruiting

A Study of E7130 in Participants With Solid Tumors

Solid Tumors

Japan
Eisai Co., Ltd.

Active, not recruiting

A Study of E7090 in Participants With Unresectable Advanced or Metastatic Cholangiocarcinoma With Fibroblast Growth Factor Receptor (FGFR) 2 Gene Fusion

Cholangiocarcinoma

China, Japan
Eisai Co., Ltd.

Completed

A Study to Assess the Safety, Tolerability, and Pharmacokinetics of E6742 in Systemic Lupus Erythematosus Participants

Lupus Erythematosus, Systemic

Japan
Eisai Co., Ltd.

Completed

Quality of Life in New Treatable Therapy as Rabeprazole Option for Refractory Reflux Esophagitis

Refractory Reflux Esophagitis

Japan
Eisai Co., Ltd.

Completed

Compare the Efficacy and Safety of Donepezil Hydrochloride 23 mg Treatment With Continuation of Donepezil Hydrochloride 10 mg Treatment in Japanese Subjects With Severe Alzheimer's Disease

Alzheimer's Type Dementia

Japan
Eisai Co., Ltd.

Completed

A Study in Patients With Amyotrophic Lateral Sclerosis (ALS)

Amyotrophic Lateral Sclerosis (ALS)

Japan
Eisai Co., Ltd.

Completed

A Study of Lemborexant in Chinese Participants With Insomnia Disorder

Sleep Initiation and Maintenance Disorders

Taiwan, China
Eisai Co., Ltd.

Completed

Post-marketing Surveillance of Long-term Administration of Inovelon Tablets in Patients With Lennox-Gastaut Syndrome

Lennox-Gastaut Syndrome

Japan
Eisai Co., Ltd.

Completed

A Study of Tazemetostat in Participants With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma

Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma

Japan
Eisai Co., Ltd.

Completed

Investigation of the Clinical Safety and Efficacy of Long-term Treatment With Fycompa Tablets in Adolescence Epilepsy Patients With Partial-onset Seizures (With or Without Secondary Generalized Seizures) or Primary Generalized Tonic-clonic Seizures (FYC02T)

Partial Seizures (With or Without Secondary Generalized Seizures) | Primary Generalized Tonic-clonic Seizures

Japan
Eisai Co., Ltd.

Completed

A Study of Overall Survival in Participants With Unresectable Hepatocellular Carcinoma

Neoplasms | Carcinoma | Neoplasms, Glandular and Epithelial | Carcinoma, Hepatocellular

Japan
Organon and Co
Quintiles, Inc.

Completed

Study of Mometasone Furoate Nasal Spray and Oxymetazoline Nasal Spray Given Together Once A Day To Treat Seasonal Allergic Rhinitis (P04500)

Seasonal Allergic Rhinitis
Eisai Co., Ltd.

Completed

A Trial of Lenvatinib (E7080) in Radioiodine (131 I)-Refractory Differentiated Thyroid Cancer in China

Differentiated Thyroid Cancer (DTC)

China
Eisai Co., Ltd.

Completed

Study of Tazemetostat in Participants With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma With EZH2 Gene Mutation

Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma

Japan
Eisai Co., Ltd.

Completed

Phase 1 Study of E7090 in Subjects With Solid Tumor

Tumors

Japan
Eisai Co., Ltd.

Completed

A Phase 2 Study of E6011 in Subjects With Rheumatoid Arthritis Inadequately Responding to Biologics

Rheumatoid Arthritis

Japan
Eisai Co., Ltd.

Completed

A Dose Response Study of E6011 in Participants With Rheumatoid Arthritis Inadequately Responding to Methotrexate

Rheumatoid Arthritis

Japan
Eisai Co., Ltd.

Completed

A Study of E7080 in Subjects With Advanced Thyroid Cancer

Thyroid Cancer

Japan
Eisai Co., Ltd.

Completed

Post-marketing Surveillance of Administration of Botulinum Toxin Type B(NerBloc)-Investigation of the Clinical Condition and Safety in Patients With Cervical Dystonia

Cervical Dystonia

Japan

3

Subscribe